These results identify leptin as a circulating peptide that potently counteracts hepatic steatosis via action on the brain, and suggest that impaired leptin transport across the BBB represents a potential key contributor to obesity-related development of NAFLD. This evidence concerns the gene LEP and Hepatic steatosis.